Tarsus Pharmaceuticals
TARS
TARS
92 hedge funds and large institutions have $387M invested in Tarsus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
54% more capital invested
Capital invested by funds: $252M → $387M (+$135M)
24% more funds holding
Funds holding: 74 → 92 (+18)
4.94% more ownership
Funds ownership: 75.04% → 79.98% (+4.9%)
Holders
92
Holding in Top 10
4
Calls
$329K
Puts
$67K
Top Buyers
| 1 | +$36.1M | |
| 2 | +$13.4M | |
| 3 | +$3.52M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$2.98M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.83M |
Top Sellers
| 1 | -$15M | |
| 2 | -$14.5M | |
| 3 | -$4.61M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$2.78M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$1.63M |